GlassScriptPhysician profile
Roy M Lerman
NPI 1588767180
$7,449.96
in general payments reported to CMS, 2019-2025
48 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $395 · 2021: $781 · 2022: $1,287 · 2023: $945 · 2024: $1,933 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,906 · Travel and Lodging: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,906.07 |
| Travel and Lodging | $289.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,496.35 | 2019-2025 | Proclaim, Eterna, Octrode |
| Relievant Medsystems, INC. | $827.96 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $743.77 | 2019-2025 | Intracept, General - Pain Management, Na |
| Vertos Medical, INC. | $709.52 | 2020-2024 | Mild Device Kit |
| Curonix LLC | $304.58 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Providence Medical Technology, INC. | $215.13 | 2022-2025 | |
| Si-Bone, INC. | $199.50 | 2019-2025 | |
| Mdd US Operations, LLC | $189.94 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.92 | 2022-2025 | Relistor |
| Merz Pharmaceuticals, LLC | $175.35 | 2022-2025 | Xeomin |
| Painteq LLC | $163.31 | 2024 | Painteq |
| Nevro Corp. | $152.34 | 2020-2024 | Senza |
| Vertiflex, INC. | $141.91 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $138.14 | 2024-2025 | |
| Nalu Medical, INC. | $123.66 | 2021-2024 | Nalu Neurostimulation System |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Lerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.